Our Solution
Learn about Our Solution and its Wound Healing properties.
Learn about Our Solution and its Wound Healing properties.
View and Learn the process of making HemaWeave.
Explore the Huge Market of Infection-Preventive Technologies.
Know more about the people behind HemaWeave.
Discover the future possibilities of HemaWeave.
No person should develop an infection in the very place meant to help them heal. Such preventable complications are unacceptable, and our team is working to stop infection at the source through the development of advanced antimicrobial and hemostatic wound scaffolds.
Although surgical procedures are often necessary to save lives, they can ironically place them in further danger. Surgical site infections (SSIs) can be severe and potentially lethal, leading to unnecessary complications, prolonged recovery, sepsis, and even death resulting from infection-related complications rather than the original condition. In fact:
Current wound dressings often lack both strong antimicrobial protection and rapid clotting capability, increasing the risk of infection and prolonged recovery. There is a need for an advanced wound dressing that promotes rapid clotting, provide structural support for healing, and helps prevent infection through antimicrobial functionality.
Our project focuses on the development of electrospun chitosan-based nanofiber wound scaffolds designed to improve wound healing and reduce infection risk. Through biomaterial formulation, electrospinning fabrication, and characterization testing, our team is developing a more advanced wound healing solution. The scaffold address limitations in current wound dressing technologies by providing: